Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.
about
Optimization of feline immunodeficiency virus vectors for RNA interferenceMechanisms of prolonged presynaptic Ca2+ signaling and glutamate release induced by TRPV1 activation in rat sensory neuronsMethods, potentials, and limitations of gene delivery to regenerate central nervous system cellsFine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.FIV Gag: virus assembly and host-cell interactions.Di-ethylhexylphthalate (DEHP) modulates cell invasion, migration and anchorage independent growth through targeting S100P in LN-229 glioblastoma cellsFeline immunodeficiency virus as a gene transfer vector in the rat nucleus tractus solitariiDevelopment of multigene and regulated lentivirus vectors.The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent.Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virionsOrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection.Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gagIn vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins.Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptorThe inside out of lentiviral vectorsSelective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virusLentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alphaAltered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.Integration site choice of a feline immunodeficiency virus vector.Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes.Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells.Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function.Ebola virus glycoprotein 1: identification of residues important for binding and postbinding eventsLentiviral vector gene transfer to porcine airways.Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral VectorsFeline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defectHuman, Pig, and Mouse Interferon-Induced Transmembrane Proteins Partially Restrict Pseudotyped Lentiviral Vectors.New therapeutic opportunities for hepatitis C based on small RNA.Lentivirus vector can be readministered to nasal epithelia without blocking immune responsesSelection of drug-resistant feline immunodeficiency virus (FIV) encoding FIV/HIV chimeric protease in the presence of HIV-specific protease inhibitorsHuman gene therapy vectors derived from feline lentiviruses.Lentiviral-mediated phenotypic correction of cystic fibrosis pigs.Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).
P2860
Q24671047-F5BE09DB-2581-4080-AAF9-4CEAE55E1D24Q28571331-3A3FBA6E-9D8D-4DA7-89D1-F95F3B08342DQ28766660-40504D75-66D2-427B-9B1C-C75A39CA0CCBQ33587317-9C68F3BC-3848-4F29-9729-7E015281C6D4Q33653971-917E619A-208E-451B-8BD3-34930CF1FF65Q33742292-349D833C-4956-4A81-9EA6-4DEAED03E4EAQ33778126-911B9109-5BA8-4694-B86C-7F9ACD4B2FD9Q33787285-864D433B-5D17-475E-804A-983BAA840787Q33817487-7CF41964-08F1-439B-BB9F-AB719D0C963DQ33851781-6E841A4E-160A-41B7-A905-76C4DC957213Q33966659-E2FA2EEE-8761-4CE8-93E4-CA470F020A3CQ33990752-83DD1935-141F-4BFE-AD91-791213D9305DQ34028579-9F3A56F6-6591-422C-B56F-F17D10F2656FQ34045671-57689CA8-AAE4-43F6-B1B7-BA8E77436CEAQ34329784-6E2F88ED-CFA6-4731-9595-A7D9A6C088B5Q34344453-9E904145-8526-4E40-A185-051C0E31A78FQ34550397-585B72BD-14F7-4A77-A9D1-4D88C4D0B142Q34633466-D0E89C6E-FC96-4C88-BF09-5213FCD7F51AQ34734101-D3865062-28D7-4FCE-BEF4-41CD14553BA3Q34976813-80FB9A18-C1A7-4092-B645-592B6FE15CD5Q35024024-8D7328A8-AB5A-4B8F-B19B-7CCF89E16461Q35024080-A13DAB2C-5BAF-482F-BE07-9E6DD7ED4586Q35077801-C85F34C6-B67A-4AE4-8701-758E970EC98FQ35633815-AAB0219D-B29B-42BD-BF65-1ECF0E7ABEF5Q35803032-4DFB755B-8AAC-453B-8FC6-04EA9FA3A314Q35848097-C5DB77E6-D9D8-4118-9EF6-85F1668A2842Q35880117-89B8848B-585C-4788-B8B9-84F182DE73F7Q35914444-B1A140D5-0AA0-4094-A09F-33FE7C7455CCQ36438300-79C5949F-AB0E-41CA-9B84-AE8538156FB3Q36470890-A85F2858-F119-4FC1-9077-17600D41C181Q36587580-D1EFC43C-0775-4855-9272-FA72E3B47184Q36807130-75A507EF-65D2-4F23-B6D7-2CF5C8227A20Q36825419-27E7771B-A22E-4F84-B77C-FC401D4AED97Q36921336-2034CFF8-C515-4591-B0E9-C2C3ADF16400Q36949698-F1E3E7E9-3126-40B4-9BB0-4FB89F2D40ACQ37036823-1E862122-6043-40A4-89D2-4A2DEAA4E89AQ37090721-58D12FF2-E0AA-4D0D-A4A7-AF3B9F315A7EQ37265494-F9324E15-2AFB-4907-AC93-4F3700BE60ABQ37355990-B32CD7A5-E146-4A7F-BAEF-A8E4A76BBC1BQ37615161-BA679C2A-68FA-4C9A-828A-E8A48ED6C84B
P2860
Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Minimum requirements for effic ...... mmunodeficiency virus vectors.
@ast
Minimum requirements for effic ...... mmunodeficiency virus vectors.
@en
type
label
Minimum requirements for effic ...... mmunodeficiency virus vectors.
@ast
Minimum requirements for effic ...... mmunodeficiency virus vectors.
@en
prefLabel
Minimum requirements for effic ...... mmunodeficiency virus vectors.
@ast
Minimum requirements for effic ...... mmunodeficiency virus vectors.
@en
P2093
P2860
P1433
P1476
Minimum requirements for effic ...... mmunodeficiency virus vectors.
@en
P2093
B L Davidson
J C Johnston
K P Campbell
S L Sauter
P2860
P304
P577
1999-06-01T00:00:00Z